Debbie's Brain Cancer Research Fund Benefiting brain cancer research at Upstate Medical University, Syracuse. |
|
|
Donate directly to Debbie's Fund at Upstate:
100% of all donations go to Debbie's Brain Cancer Research Fund at Upstate Cancer Center. Your donation is 100% tax deductible. The Foundation for Upstate Medical University will send you a receipt for tax purposes.. How to Sponsor When you click "Donate/Sponsor", you will be directed to the donation page at Upstate Cancer Center. At the bottom of the page, complete the Tribute section by including the name of the participant you are sponsoring. |
Donate through Facebook
Are you on Facebook? Facebook does not charge fees for registered non-profit fundraisers such as ours. 100% of all donations go to Debbie's Brain Cancer Research Fund at Upstate Cancer Center. Donate by mail
Check payable to: Debbie's Brain Cancer Research Fund Mail to: Upstate Foundation 750 E Adams Street, CAB 326, Syracuse, NY 13210 Your donation is 100% tax deductible. The Foundation for Upstate Medical University will send you a receipt for tax purposes. |
About Debbie's Brain Cancer Research Fund
Debbie Schutzendorf Gregg started “Debbie’s Brain Cancer Research” fund on July 4th 2012 at the Cazenovia foot races in appreciation for her doctor, Dr. Thomas E. Coyle MD at Upstate Cancer Center. Debbie was diagnosed with anaplastic astrocytoma brain cancer in January of 2008. Coyle cared for Debbie from diagnosis until she passed away in 2012. Coyle, is not only a doctor dedicated to neuro-oncology research specializing in brain tumors, but also he is an outdoorsman and an avid runner. Debbie loved that! Most importantly, he was compassionate and dedicated to helping Debbie. Debbie believed that of all things, Coyle’s brain cancer research could make a difference for others in the future.
Prior to Debbie passing away, she raised over $52,000 for the fund. Debbie inspired! Many have since generously donated to the fund and Debbie’s family continues to raise funds in memory of Debbie through various fundraisers. Please help continue our mission and make a donation today in memory of Debbie for brain cancer research.
Click Here for Article in Cazenovia Republican, July 2020
Debbie Schutzendorf Gregg started “Debbie’s Brain Cancer Research” fund on July 4th 2012 at the Cazenovia foot races in appreciation for her doctor, Dr. Thomas E. Coyle MD at Upstate Cancer Center. Debbie was diagnosed with anaplastic astrocytoma brain cancer in January of 2008. Coyle cared for Debbie from diagnosis until she passed away in 2012. Coyle, is not only a doctor dedicated to neuro-oncology research specializing in brain tumors, but also he is an outdoorsman and an avid runner. Debbie loved that! Most importantly, he was compassionate and dedicated to helping Debbie. Debbie believed that of all things, Coyle’s brain cancer research could make a difference for others in the future.
Prior to Debbie passing away, she raised over $52,000 for the fund. Debbie inspired! Many have since generously donated to the fund and Debbie’s family continues to raise funds in memory of Debbie through various fundraisers. Please help continue our mission and make a donation today in memory of Debbie for brain cancer research.
Click Here for Article in Cazenovia Republican, July 2020
Upstate Cancer Research is a multidisciplinary enterprise, encompassing the efforts of many Upstate faculty and collaborators at other institutions, with the goal to translate research into potential cures, technologies and other products.
Affiliated with the State University of New York, Upstate's mission is to improve the health of the community through education, biomedical research and health care. As a biomedical research enterprise, Upstate focuses on the most prevalent human diseases, including cancer, diabetes, heart disease, nervous system disorders, vision, and infectious diseases. The quest for treatments and cures is built upon expertise in structural, molecular and systems biology. Upstate also offers many clinical trials for patients. The Upstate University Health System serves 1.8 million people, often the most seriously ill and injured, and includes Upstate University Hospital; Upstate University Hospital at Community Campus; Upstate Golisano Children's Hospital, and numerous satellite sites. |
Upstate forms Brain Tumor Research Group
To better meet the challenges of treating brain cancer, Upstate Medical University’s Precision Neuro-Oncology Program pools the expertise of the best minds in a variety of scientific fields. The newly formed Brain Tumor Research Group involves neurosurgeons, pathologists and neuroscientists from Upstate Medical University and biomedical scientists from Cornell University to analyze and test brain tumors with the goal of increasing the number of available brain cancer treatments. Working as a multidisciplinary team, the experts store tumor samples in a unique tumor bank, perform molecular profiling and biological assays and work toward predicting the progression of brain cancer and its outcome. In addition, the group works to develop clinical trials that could lead to new cancer treatments and possibly to applications for other diseases as well. This team draws on a special resource—Upstate’s brain tumor cell bank, which has been maintained by the department of neurosurgery for more than 25 years to support its research. Hundreds of tissue samples from brain tumors are carefully stored in a deep freeze at the Neuroscience Research Building. These samples can be thawed, cultured and studied to help understand how tumors behave. The spirit of collaboration behind this project has already been established. One of Upstate’s newest faculty members, Mariano Viapiano, PhD, came from Harvard University to continue working with Upstate faculty members he had long associated with, including neuroscience professor Russell “Rick” Matthews, PhD, and pathologist Robert Corona Jr., DO, and now neurosurgeon Lawrence Chin, MD. This collaboration integrates the work done at Upstate’s Neuroscience Research Building with that taking place in the Central New York Biotechnology Accelerator, the Cancer Center, the Cord Blood Bank and Molecular Genetics Laboratory and the laboratory of Charles Danko, PhD, at Cornell University’s Baker Institute. Working together, neurosurgeons can become involved in basic science, neuroscience researchers can pursue topics in oncology, and pathologists can help develop molecular diagnostics. The aim is to create new brain cancer treatments derived from the intensive research and analysis of the tumor samples. The program hopes to become a national reference institution for precision diagnostics and personalized treatment of brain cancer. —Taken from the spring 2017 issue of Cancer Care magazine. Caption: Frozen samples of brain cancer tumors can be carefully thawed, put in a nourishing medium and placed in a body-temperature incubator to bring them back to life. Above, research specialist Sharon Longo holds a flask in which the cells are placed for this nurturing process. Researchers can study to see, for example, whether the cells will grow a new tumor or how they might react to various chemicals. In addition to frozen tissue, fresh tumor cells can also be studied. Photograph by Robert Mescavage. |
